Skip navigation
Speakers

Strategic Forecasting, Accounting Estimates, Analytics and Financial Reporting for Life Science Companies

November 15-16, 2018
  • Philadelphia, PA

Ankit Agrawal
Director, Contracts and Pricing, U.S. Business Unit
Takeda Pharmaceuticals

Jeff Baab
Vice President, Life Sciences
daVIZta Inc., The Revenue Analytics Company

Brian R. Barbash
Partner
Pharosity Consulting

Eric Benson
Audit & Assurance Manager
Deloitte & Touche LLP

Larry Breen
Director of Financial Planning and Analysis / Revenue Analytics
Sunovion Phamaceuticals

Kary Callahan
Associate Director, Commercial Finance
Paratek Pharmaceuticals

Richard Capasso
Executive Director, Americas Financial Accounting Advisory Services
Ernst & Young LLP

Patrick R. Coyle
Vice President, Financial Planning and Analysis
Insmed

Michael Domanico
Vice President of Finance, Revenue
Sandoz

Tom Evegan
Managing Director
Cumberland Consulting Group

Brian Fallica, Ph.D.
Associate Principal
IQVIA’s US Market Access Strategy Consulting

Anthony Fiordaliso
Vice President, Americas Finance
Astellas Pharma

John Glover
Partner
Pearl Management Consulting

Luke Greenwalt
General Manager
IQVIA’s US Patient Access & Affordability Solutions

Rita Johnson-Greene
US Commercial Operations Lead
Spark Therapeutics

Pat Henahan
former Vice President of Finance
Hospira

Romit Kamdar
Partner
Akara Group LLC

Murray Kay
Former Senior Vice President & CFO, Solvay Pharmaceuticals;
Former Commercial Controller, AbbVie & Abbott Laboratories

John Lewis
Director, Product Strategy and Development
BPI Technologies

Luyan Li, CPA
Director of Finance, Treasurer
Medac Pharma, Inc.

Jennifer Lospinoso
Managing Director
KPMG

Michael Makovec
Partner
Deloitte & Touche LLP

Mike McCarthy
Partner
Pharosity Consulting

Jeffrey R. Miller, CPA
Senior Director, Commercial Operations Revenue Management
Impax Labs/Amneal Pharmaceuticals

Karim Munir
Director, Corporate Financial Reporting and Global Consolidation
Bristol-Myers Squibb

Patrick Park, PharmD, MBA
Director, Forecasting and Business Analytics
Daiichi Sankyo, Inc.

Dharmesh Patel
Director of Gross To Net Operations
GlaxoSmithKline

Shivani Patel
Director, Advanced Analytics
Integrichain

Chris Prentiss
Chief Accounting Officer
Adamas Pharmaceuticals, Inc.

Karl Ramas
Senior Manager, Pricing, Contracting and Market Access
HighPoint Solutions

Neelabh Saxena
Senior Principal, Pricing, Contracting and Market Access
HighPoint Solutions

Brad Schulte
Senior Manager
Deloitte & Touche LLP

Jennifer Sharpe
Senior Director, Revenue Analytics Collaborative
daVIZta Inc., The Revenue Analytics Company

Bob Steller
Industry Principal, Life Sciences
Vistex

John D. Stitt
Hospital and Specialty US Finance Lead
Merck & Co

Nate Taninecz
Vice President, Life Sciences Industry
Model N

Joe Warchol
Executive Director, U.S. Business Operations Finance
Amgen

Jennifer Winterhalter
Vice President, Revenue Management
Amneal Pharmaceuticals/Impax

Walt Worsham
Senior Manager
Deloitte & Touche LLP

Alia Zuhfer
Associate Director, Gross-to-Net Sales Analysis and Reporting
Bristol-Myers Squibb

Ankit Agrawal
Director, Contracts and Pricing, U.S. Business Unit
Takeda Pharmaceuticals

Jeff Baab
Vice President, Life Sciences
daVIZta Inc., The Revenue Analytics Company

Brian R. Barbash
Partner
Pharosity Consulting

Eric Benson
Audit & Assurance Manager
Deloitte & Touche LLP

Larry Breen
Director of Financial Planning and Analysis / Revenue Analytics
Sunovion Phamaceuticals

Kary Callahan
Associate Director, Commercial Finance
Paratek Pharmaceuticals

Richard Capasso
Executive Director, Americas Financial Accounting Advisory Services
Ernst & Young LLP

Patrick R. Coyle
Vice President, Financial Planning and Analysis
Insmed

Michael Domanico
Vice President of Finance, Revenue
Sandoz

Tom Evegan
Managing Director
Cumberland Consulting Group

Brian Fallica, Ph.D.
Associate Principal
IQVIA’s US Market Access Strategy Consulting

Anthony Fiordaliso
Vice President, Americas Finance
Astellas Pharma

John Glover
Partner
Pearl Management Consulting

Luke Greenwalt
General Manager
IQVIA’s US Patient Access & Affordability Solutions

Rita Johnson-Greene
US Commercial Operations Lead
Spark Therapeutics

Pat Henahan
former Vice President of Finance
Hospira

Romit Kamdar
Partner
Akara Group LLC

Murray Kay
Former Senior Vice President & CFO, Solvay Pharmaceuticals;
Former Commercial Controller, AbbVie & Abbott Laboratories

John Lewis
Director, Product Strategy and Development
BPI Technologies

Luyan Li, CPA
Director of Finance, Treasurer
Medac Pharma, Inc.

Jennifer Lospinoso
Managing Director
KPMG

Michael Makovec
Partner
Deloitte & Touche LLP

Mike McCarthy
Partner
Pharosity Consulting

Jeffrey R. Miller, CPA
Senior Director, Commercial Operations Revenue Management
Impax Labs/Amneal Pharmaceuticals

Karim Munir
Director, Corporate Financial Reporting and Global Consolidation
Bristol-Myers Squibb

Patrick Park, PharmD, MBA
Director, Forecasting and Business Analytics
Daiichi Sankyo, Inc.

Dharmesh Patel
Director of Gross To Net Operations
GlaxoSmithKline

Shivani Patel
Director, Advanced Analytics
Integrichain

Chris Prentiss
Chief Accounting Officer
Adamas Pharmaceuticals, Inc.

Karl Ramas
Senior Manager, Pricing, Contracting and Market Access
HighPoint Solutions

Neelabh Saxena
Senior Principal, Pricing, Contracting and Market Access
HighPoint Solutions

Brad Schulte
Senior Manager
Deloitte & Touche LLP

Jennifer Sharpe
Senior Director, Revenue Analytics Collaborative
daVIZta Inc., The Revenue Analytics Company

Bob Steller
Industry Principal, Life Sciences
Vistex

John D. Stitt
Hospital and Specialty US Finance Lead
Merck & Co

Nate Taninecz
Vice President, Life Sciences Industry
Model N

Joe Warchol
Executive Director, U.S. Business Operations Finance
Amgen

Jennifer Winterhalter
Vice President, Revenue Management
Amneal Pharmaceuticals/Impax

Walt Worsham
Senior Manager
Deloitte & Touche LLP

Alia Zuhfer
Associate Director, Gross-to-Net Sales Analysis and Reporting
Bristol-Myers Squibb